Research ArticleBasic Sciences
Copper-67-Labeled Monoclonal Antibody Lym-1, a Potential Radiopharmaceutical for Cancer Therapy: Labeling and Biodistribution in RAJI Tumored Mice
Shrikant V. Deshpande, Sally J. DeNardo, Claude F. Meares, Michael J. McCall, Gregory P. Adams, Min K. Moi and Gerald L. DeNardo
Journal of Nuclear Medicine February 1988, 29 (2) 217-225;
Shrikant V. Deshpande
Sally J. DeNardo
Claude F. Meares
Michael J. McCall
Gregory P. Adams
Min K. Moi


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Copper-67-Labeled Monoclonal Antibody Lym-1, a Potential Radiopharmaceutical for Cancer Therapy: Labeling and Biodistribution in RAJI Tumored Mice
Shrikant V. Deshpande, Sally J. DeNardo, Claude F. Meares, Michael J. McCall, Gregory P. Adams, Min K. Moi, Gerald L. DeNardo
Journal of Nuclear Medicine Feb 1988, 29 (2) 217-225;
Copper-67-Labeled Monoclonal Antibody Lym-1, a Potential Radiopharmaceutical for Cancer Therapy: Labeling and Biodistribution in RAJI Tumored Mice
Shrikant V. Deshpande, Sally J. DeNardo, Claude F. Meares, Michael J. McCall, Gregory P. Adams, Min K. Moi, Gerald L. DeNardo
Journal of Nuclear Medicine Feb 1988, 29 (2) 217-225;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Labeling Antibodies
- In vivo Evaluation of 177Lu- and 67/64Cu-Labeled Recombinant Fragments of Antibody chCE7 for Radioimmunotherapy and PET Imaging of L1-CAM-Positive Tumors
- High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment
- High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment